CD4 and melanoma: We also interpret the fact that NK1.1+ cell depletion reduces the number of relapses to mean either that TRP-1-specific CD4+ T cells reject melanoma cells more completely or experience exhaustion to a lesser degree in the absence of NK1.1+ cells35 as has been suggested in viral infection models.